PlainRecalls
FDA Drug Moderate Class II Terminated

Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 UNited States. Manufactured by: Lupin Limited, Pithampur, (M.P.) 454 775 India NDC# 68180-316-06

Reported: October 27, 2021 Initiated: October 8, 2021 #D-0027-2022

Product Description

Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 UNited States. Manufactured by: Lupin Limited, Pithampur, (M.P.) 454 775 India NDC# 68180-316-06

Reason for Recall

Out of specification result observed in a dissolution test at the 9-month long term stability time point.

Details

Units Affected
1,902 bottles
Distribution
Distributed Nationwide in the USA.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 UNited States. Manufactured by: Lupin Limited, Pithampur, (M.P.) 454 775 India NDC# 68180-316-06. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 1,902 bottles.
Why was this product recalled?
Out of specification result observed in a dissolution test at the 9-month long term stability time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 27, 2021. Severity: Moderate. Recall number: D-0027-2022.